In a preprint posted on BioRxiv this week, Decode researchers used nanopore sequencing to characterize structural variants in more than 1,800 Icelandic individuals.
Investigators compared expression in different men across the genes from three commercial panels, arguing that the findings highlight important unknowns.
Findings of a new study point to the need for technological solutions and education to improve local healthcare providers' ability to discuss genetic information with patients.
Recent studies question the clinical utility of tumor mutational burden as a biomarker for immuno-oncology response, and the FDA clearance includes no therapeutic indications.
The company released data showing that its panel detects early-stage liver cancer with 71 percent sensitivity compared to 25 percent for the standard test.
Despite the step-up in FDA action against labs offering PGx tests, the success of these programs suggests that access to them isn't being stifled as some feared.
Accredited by the same group behind MP3 audio, the new genomics standard promises more efficient data handling, but fans of GA4GH file formats are pushing back.
In a survey conducted by an association working group, 40 percent of respondents said they are already offering TMB, with most others planning to do the same within the year.
Due out in December, the Magnis automated library prep instrument is meant to be an affordable and easy way for researchers to use Agilent's SureSelect kits.
The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.
In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.
